The study aimed to compare the basal plasma levels of inflammatory markers (MCP-1, IL-1ra and IL-1β) in Parkinson Disease group (PDG) with control healthy subjects (control group, CG), as well to investigate the acute and chronic effects of an aquatic physiotherapy program on these biomarkers in PDG. Firstly, a rest blood sampling was taken from antecubital vein of the PD and CG. After, the PD individuals were submitted to a supervisioned aquatic physiotherapy program during 1 month, twice a week (60 min/session). In order to evaluate the acute and chronic effects of the intervention on the biomarkers, blood samples were in 4 times: before the exercise program (pre), immediately after the first session, 48 h after the exercise session and 1 month after the intervention. It was observed higher levels of the pro-inflammatory cytokines IL-1β and MCP-1 and reduced levels IL-1ra in PDG compared to the CG. Regarding the intervention effects in PDG, a remarkable reduction on IL-1β and MCP-1 levels at 48 h when compared to the basal were found. Furthermore, after 1 month, it was observed diminished levels of MCP-1 in combination to an increase on IL-1ra. Our data support the idea that an inflammatory status is linked to PD and that MCP-1 and IL-1ra could be taken as promising biomarkers in this condition. We also demonstrated that an aquatic physiotherapy program may offer a potential intervention able to attenuate immune responses in PD individuals in a short and long-term perspective.
Introduction
Parkinson disease (PD) is a progressive neurodegenerative disorder that affects more than 1% of the population aged over 55 years and older in the world [1, 2] . Clinically, PD is characterized mainly by motor symptoms such as resting tremor, bradykinesia, postural instability and muscular rigidity [3] . Altogether, these signs contribute to the development of muscle weakness, functional performance decrease [4, 5] , worse health status and lost productivity [6] .
The progressive degeneration and loss of nigrostriatal dopaminergic neurons are considered the most important hallmark of PD. In this context, it has been proposed that the neuronal apoptosis due to increased levels of cytokines and apoptosis-related proteins might be related, at least in part, to the degeneration of the nigrostriatal dopaminergic neurons; suggesting that the neuroinflammation plays a pivotal role in PD pathogenesis [7] [8] [9] .
The interleukin-1 family compromises 11 cytokines, which have a key role in the regulation of pro-inflammatory response to infectious and/or damage events [10, 11] . The interleukin 1 beta (IL-1β) is one of the most potent IL-1 cytokine, being produced mainly by activated macrophages, and proteolytically processed in to active form by caspase 1 [11] . The IL-1β acts as mediators of inflammatory response, inducing cell proliferation, differentiation, and apoptosis. In addition, IL-1 β induces the expression of cyclooxygenase-2 in CNS, contributing for neuronal death, dementia and pain hypersensitivity [12] . On the other hand, the interleukin-1 receptor antagonist (IL-1ra) is a natural antagonist of IL-1 by binding to IL-1 receptor 1, whereas IL-1ra blocks the IL-1α/β biological activity [11] .
Increased expression of IL-1 has been found in brain, cerebrospinal fluid and peripheral blood of patients with PD compared to the age-matched control group [13] [14] [15] [16] . Interestingly, the gene polymorphism of IL-1β increases the risk of PD [17] .
Moreover, the chronic inflammatory response in PD patients is accompanied by higher chemotaxis activity of macrophages and others immune cells to inflamed site. In this way, astrocytes secrete chemokine monocyte chemoattractant protein-1 (MCP-1), which exerts a key role in the recruitment of peripheral pro inflammatory monocytes [18] as well as partially responsible for migration and infiltration of peripheral immune cells into the CNS [19] . Importantly, higher levels of MCP-1 were also detected in peripheral blood of PD patients [16] .
Altogether, these findings reinforce the strong link between PD and MCP-1 and IL-1 system and led us to hypothesize that strategies that modulate the immune system might be relevant in PD management. In this context, physical exercise have been pointed out as a promising non-pharmacological and low-cost strategy able to reduce the risk of neurodegeneration diseases [20, 21] as well to improve clinical outcomes in PD patients through neuroprotection [22] .
Several mechanisms have been proposed as major mediators of exercise-induced neuroprotection in PD, with strong experimental evidence in PD models suggesting the anti-inflammatory properties [23] [24] [25] [26] . Despite these findings, clinical data regarding the modulation of inflammatory markers as potential molecular mechanisms involved to the beneficial effects of exercise in PD individuals are scarce. In fact, there are no evidences demonstrating the modulation of MCP-1 and IL1ra levels in response to exercise in this population.
Among the different modalities of physical exercise observed to exert beneficial effects for PD patients, aquatic physiotherapy programs have become a recent focus of attention due it unique proprieties takes an buoyancy, turbulence, hydrostatic pressure, and resistance that can be used to gain a range of exercise benefits [27, 28] . In PD treatment, the aquatic environment facilitates to move more easily while reducing the fear of falling and also to be consider safe and enjoyable with no adverse events [29] [30] [31] . A systematic review published by Perez and Cancela [32] and a recent study conducted by Kurt and colleagues [33] showed that water-based exercise interventions in PD patients significantly improved motor symptoms, functional mobility, and qualityof-life measures. Even though, the molecular mechanisms linked to these beneficial outcomes are not elucidated.
In view of all these considerations, the purposes of the present study were 1) to compare the basal plasma levels of MCP-1, IL-1ra and IL-1β in PD patients with control healthy subjects; 2) and to investigate the acute and chronic effects of an aquatic physiotherapy program on these biomarkers in PD patients.
Material and methods

Participants
Twelve patients with idiopatic PD (PD group, PDG) and fourteen healthy individuals matched by age and gender (Control group, CG) participated in the present study. The participants were of both gender and over to 51 years old.
For the PDG, inclusion criteria were diagnosis of idiopathic PD confirmed by a neurologist and Levodopa use. Neoplastic illness, infection, cardiopulmonary, vascular or other internal medical conditions, the use of oral or local corticosteroids and history of neurosurgical procedure were considered the exclusioncriteria.
Smoke and the use of inflammatory drugs were considered exclusion criteria for PDG and CG. Furthermore, all participants must be physically inactive, which are considered as less than 1 h of physical exercise in the previous 3 months.
Medication doses for each PD patient remained the same as normally administered by their leading neurologist (disease stage-adjusted).
Finally, all participants gave their written consent before participation in the study, which was approved by Local Ethic Committee (number 1.373.911).
Experimental design
Firstly, it was evaluated the inflammatory markers in both groups: PDG and CG. For that, a rest blood sampling was taken from antecubital vein of the individuals (15 mL).
After, the PDG was submitted to anaquatic physiotherapy program, carried out in the indoor swimming pool (depth 1.1 m, mean water temperature 32°C) of the Centro Universitário Metodista -IPA. The intervention was done in group, during 1 month, twice a week, in the afternoon period (3:30 p.m. to 4:30 p.m.) with each session lasting 60 min. These characteristics are in accordance to other similar programs [34, 35] .
Specifically, the aquatic physiotherapy program consisted in a concurrent exercise protocol, ie, the combination of aerobic and resistance training was used, which has been shown to improve physical health and fitness. This program followed the recommendations of the American College of Sports Medicine [36] . The sessions were performed as follows: a) warm-up: with passive stretching of lower limbs, exercises of dissociation of waists and double task; b) resisted exercises: composed by exercises to strengthen paravertebral and posterior chain of trunk and limbs, gait exercises, balance exercises and exercises of proprioception; c) integration exercise: that consisted on games with playful connotations were carried out to stimulate group integration; d) relaxation. Importantly, all sessions were monitored and supervised by prepared physical therapy students to ensure the safety of participants. Also, the participants received constant verbal motivation during the training and were asked to adhere to their regular diet throughout the intervention course.
In order to evaluate the acute and chronic effects of the intervention on the inflammatory markers in the PDG, blood samples were taken (15 mL) in the antecubital region of individuals in 4 times: before the exercise program (pre), immediately after the first session, 48 h after the exercise session and 1 month after the intervention. The individuals were instructed to avoid the consumption of alcohol or caffeine-based beverage in a 24-h period prior to blood collections. All blood sampling was done during the "on" phase".
Sample procedure and inflammatory markers measurement
The whole blood samples were diluted in a proportion of 4:3 in phosphate-buffered saline (PBS, 136 mM, NaCl, 2.7 mMKCl, 7.8 mM Na2HPO4, 1.7 mM KH2PO4; pH 7.2-7.4) and centrifuged (1500 rpm, 21°C, 20 min) on Ficoll-Histopaque 1077 (Sigma, MO, USA). At this time, 1.5 mL of plasma was separated and frozen at −20°C for circulating cytokines analysis.
Systemic concentrations of antagonist receptor of interleukin-1 (IL1ra, catalog number900-K474), IL-1β (catalog number 900-K16), MCP-1 (catalog number 900-K31) were determined by Enzyme-Linked Immunosorbent Assay (ELISA) using commercial reagents (PeprotechInc, NJ, USA). The intra-assay coefficient variation was of 7.5% for all cytokines.Afterwards, the 96-well were incubated overnight with captured antibody anti-IL-1ra, IL-1β, MCP-1 diluted in 1 × PBS buffer. After blocking it for 1 h to avoid non-specific binding, it was added 100 μL of standard IL-1ra, IL-1β, MCP-1, and plasmasamples. The cytokines were detected by the use of horseradishperoxidase-labeled monoclonal antibody to each target after the addition of the 100 μL anti-human IL-1ra, IL-1β, MCP-1biotinylated; the antibodies were placed in each well and incubated for 2 h atroom temperature. The microplate was thoroughly washed to remove unbound enzymelabeled antibodies. The horseradish peroxidase ineach well was determined by the addition of 100 μL substrate solution. The reaction was stopped by the addition of 100 μL of 1 M sulfuricacid, and all readings were performed at 405 nm (emission) in a 96 well platereader (ThermoPlate, São Paulo, Brazil). The concentrations of cytokines were determined by interpolation from calibration curve and presented as pg/mL.
Statistical analysis
GPower (version 3.1.3; Franz Faul, Kiel, Germany) was used to calculate the sample size of the study and indicated that a minimum of 12 participants per group would be enough to detect an effect size (ES) of 0.85 in inflammatory cytokines (primary outcome variable) with a power of 85% and 5% significance level [50] .
Data were check for normality (Shapiro-Wilk test) and variance (Levene's). Data are presented as mean ± standard deviation (SD). Differences between PD patients and matched control group were verified through unpaired Student t-test. One way-repeated measurements ANOVA were performed to check the acute and chronic effects of the intervention on cytokine levels.If a significant effect was observed, Bonferroni post hoc was used.The cytokine response to one month of aquatic physical therapy was evaluated through a paired Student t-test. The level of statistical significance was set at p < 0.05. Data were analyzed using SPSS20.0 (SPSS, Chicago, IL, USA).
ES was calculated using Coheńs d (1988) . Threshold values for Cohen Effec Size statistics were > 0.2 (small), > 0.5 (moderate) and > 0.8 (large). Table 1 highlights the basal sample characterization for both groups. Table 2 shows important data about PDG group. Interestingly, the PDG had higher levels of the pro-inflammatory cytokines IL-1β and MCP-1 compared to the CG (Table 3 ; p < 0.001). Furthermore, PDG also presented diminished levels of plasma IL-1ra (Table 3 ; p < 0.001).
Results
For the PDG, 12 individuals were recruited. However, we are unable to collect blood samples from 3 patients, and these individuals were excluded for the study. During the intervention, no participants withdrew, and 9 successfully completed the 1 month-intervention period. All of them completed the program with a minimum attendance of 90% of the sessions.
The short term effects (immediately and 48 h after the first session) of the aquatic physiotherapy program on inflammatory markers in PDG are illustrated in Fig. 1 . It was demonstrated a significant reduction on MCP-1 at 48 h when compared to the basal period (Fig. 1A , p < 0.001, ES = 0.91). Similarly, compared to the basal period, the IL-1β levels were also decreased at 48 h (Fig. 1B, p < 0 .001, ES = 0.43). The IL-1ra levels remain unchanged in all time points evaluated: immediately and 48 h after the first session (Fig. 1C , p > 0.05).
As illustrated in Table 4 , at long term, specifically 1 month after the intervention, a remarkable reduction on MCP-1 (ES = 1.09) in combination to an increase on IL-1ra (ES = 1.00) plasma levels were found (p = 0.02). However, the intervention was not able to alter IL-1β levels.
Discussion
To the best of our knowledge, this is the first evidence demonstrating the circulating levels of MCP-1 and IL-1ra in PD individuals.
The present study also provides important insights about the impact of an aquatic physiotherapy program on cytokine modulation in this population.
Our findings are in line with several authors [13] [14] [15] [16] , since we showed elevated IL-1β levels in PD individuals compared to the CG. A novel finding that emerged from the current study was that PD patients also presented enhanced levels of MCP-1 and reduced levels of IL-ra, suggesting that these cytokines might be emerged as important biomarkers in PD. Altogether, our data contributes to the knowledge of the peripheral dysregulation in the cytokine network associated with PD and reinforce the idea this condition is accompanied by varying inflammatory manifestations [9] .
A remarkable point to discuss is that the intervention was able to modulates the inflammatory markers at short and long term. Although it was previously reported the thermal influence on immunological functioning [37, 38] , this is the first study that evaluated the effects of this exercise modality in PD individuals. It was observed that the levels of MCP-1, IL-1β and IL-1ra remained unaltered immediately after the first exercise session. Our data disagree those recently reported by Twal and colleagues [39] demonstrating reduced levels of MCP-1 and IL-1β in saliva from healthy individuals following a unique yoga session. On the other hand, the intervention did not exacerbate the pro inflammatory response in PD individuals. Previously, it was reported that strenuous or high-intensity high-volume exercise increases the systemic levels of pro inflammatory cytokines in obese individuals [40] and in heart failure patients [41] . Interestingly, Dorneles and co-workers [40] showed an acute elevation in IL-8 (an cytokine with chemotactic actions such MCP-1) production by leukocytes stimulated withLipopolysaccharide after strenuous exercise in obese individuals. Conversely, it was previously established that moderate exercise induces has anti-inflammatory effects across the elevation of anti-inflammatory cytokines (i.e. IL-1ra and IL-10) and the maintenance of pro inflammatory mediators at stable values [42] . In PD patients, cyclic exercise did not increase proinflammatory cytokines, IL-1 and IL-6, after exercise [8] . These data led us to infer that the modulation of inflammatory markers immediately after single bouts of exercise depends strictly of aspects such as the protocol, population and the evaluated fluid compartment. Comparison between groups was performed through the Student t-test for independent data or chi-square test (p < 0.05). IL-1β= Interleukin 1 beta; IL-1ra = interleukin-1 receptor antagonist; MCP-1 = Monocyte chemoattractant protein-1. Data presented in mean ± standard deviation. Comparison between groups through a Student t-test for independent data (p < 0.05). Despite we found no response immediately after the first session, the levels of MCP-1 and IL-1β were significantly reduced 48 h compared to the basal period, suggesting alateanti-inflammatory response to acute exercise. This is another relevant finding that emerged from this study since we showed for the first time that a single exercise session is able to modulate the immune system in PD individuals. However, IL-1ra levels were not changed in any time-point evaluated. Increases in plasma IL1ra concentrations are a well-established anti-inflammatory response induced by acute bouts of physical exercise in healthy humans [42] . In fact, intensive endurance exercise (60 min at 70-80% from maximal capacity) seems to increase the IL-1ra concentrations until 3-6 h after exercise [43, 44] . However, elevations in IL-1ra levels after exercise seems to be blunted in chronically inflamed diseases, such as obese and chronic kidney disease [45, 46] . Thus, the chronic low grade inflammation, condition characterized by the elevation of inflammatory mediators in order to 2-3 x compared to healthy individuals, found in chronic diseases (obesity, diabetes, chronic respiratory diseases, cardiovascular diseases and neurodegenerative diseases) may impairs the increases of IL-1ra in PD patients. We highlight that there are no evidences evaluating the acute inflammatory and biochemical response to aquatic-based exercises in patients with chronic diseases. In this way, more studies are needed to clarify the role of water environment in the control of low grade inflammation in chronic diseases.
Several studies suggest that physical training can promote an antiinflammatory environment, helping in the treatment of chronic diseases such PD and others neurodegenerative diseases [42] . In this regard, we also demonstrated that the aquatic physiotherapy program is capable to induce chronic effects on immune system in PD patients since reduced levels of MCP-1 and increased levels of IL-ra were observed 1 month after the intervention. Our data is in accordance with other evidences demonstrating that chronic physical exercise training is efficient to attenuate inflammatory mediators in different conditions such as multiple sclerosis and fibromyalgia [35, 37, 47] .
In fibromyalgia patients, water-based exercise training may reduce the systemic cytokine concentrations. In a pilot-study, Ortega and coworkers reported lower IL-8 levels after four months of aquatic exercise three times per weeks in women with fibromyalgia [48] . Moreover, the same group showed that 8 months of aquatic exercise (2x/ week) maintained at stable values the production of IL-1β and IL-6 by LPS-stimulated monocytes, lowered the release of TNF-α and increased the production of IL-10 in fibromyalgia patients [47] . In summary, these data denotes the attenuation of pro-inflammatory cytokines and the increase of immunoregulatory mediators after aquatic therapy intervention.
It was previously reported by Tuon and colleagues [26] both strength as well treadmill training during 8 weeks can decrease several pro-inflammatory cytokines, including IL-1β, in different brain area from animal model of PD. Furthermore, Goes and colleagues [25] also demonstrated elevated levels of IL-1β in striatum of a mouse model of PD, while a swimming exercise protocol during 4 weeks diminished/ prevented this inflammatory status. Interestingly, the exercised mice also showed an improvement on depressive-like behaviour, motor and cognitive declines. Similarly, endurance exercise had neuroprotective actions through the reduction of pro-inflammatory cytokines (mainly IL-1β) and preventing the activation of Toll-Like Receptor-2 downstream signaling cascade [49] . Interestingly, 1-month intervention did not alter IL-1β levels in the current study. We may suggest that this biomarker might be more sensitive to acute changes (short-term) and/ or might undergo adaptations in response to aquatic chronic intervention in PD individuals.
Summarizing, our data supports the concept that a raised inflammatory status is linked to PD as well that MCP-1 and IL-1ra could be taken as promising biomarkers in this condition. In addition, we also demonstrated that an aquatic physiotherapy program may offer a potential intervention able to attenuate immune responses in PD individuals in a short and long-term perspective. Importantly, this response seems to acts in a time-depend manner, modulating specific markers depending on the time of exposure (acute or chronic).
Notably, the present study should be considered within the context of its limitations. First, we used a quasi-experimental design with the absence of a control group. We believe that our findings will encourage future investigations with a larger sample, which could include a control group (submitted i.e. conventional physiotherapy) which could enable verify other issues such as the influence of gender on inflammatory modulation in response of an aquatic physiotherapy program in PD patients. 
